volume 15, issue 3, P238-239 2016
DOI: 10.1002/wps.20363
View full text
|
|
Share
Rudolf Uher

Abstract: test, proved to have inadequate prognostic clinical utility 6 . The recent emergence of low-cost pharmacogenomic techniques has sparked new interests in combinatorial use of allelic variations in drug transporters or metabolic genes as biomarkers that might predict drug response 7